跳至主要内容
临床试验/IRCT20161207031288N2
IRCT20161207031288N2已完成2 期

Evaluate the efficacy of nano lipid carrier drug delivery system containing tretinoin

Jarfandishan-e Navid-e Salamat (Janus) knowledge-based company0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
12 years 至 40 years(—)
性别
All

入选标准

  • 1.Aged between 12 to 40 years
  • 2.10 -50 acne lesions
  • 3.No change in diet and life style during the study
  • 4.Signed informed consent voluntarily and knowingly

排除标准

  • Long-time exposure to UV radiation
  • History of sensitivity to topical anti acne drug therapy
  • Use of topical anti acne drug therapy including AHA, BHA, benzyl peroxide, vitamin A, retin-A, antibiotics within one month prior to the study
  • Pregnancy / breastfeeding
  • History of systemic antibiotics for acne treatment within one month prior to the study

研究者

发起方
Jarfandishan-e Navid-e Salamat (Janus) knowledge-based company

相似试验

Effect of tretinoin nano lipid on acne | 临床试验